Evidence map›Paper›PMID 38666973›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Restraining

Myriam Anabel Díaz, Esteban Gabriel Vega-Hissi, María Amparo Blázquez, María Rosa Alberto, Mario Eduardo Arena

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Camel milkFrontiers in nutrition · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Myriam Anabel DíazInstituto Superior de Investigaciones Biológicas (INSIBIO, CONICET-UNT), Chacabuco 461, San Miguel de Tucumán CP 4000, Argentina.
Esteban Gabriel Vega-HissiInstituto Multidisciplinario de Investigaciones Biológicas (IMIBIO-SL), Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Ejército de Los Andes 950, San Luis CP 5700, Argentina.ORCID 0000-0002-6920-0903
María Amparo BlázquezDepartament de Farmacologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de València, Avd. Vicent Andrés Estellés s/n, Burjasot, 46100 Valencia, Spain.ORCID 0000-0001-7673-9328
María Rosa AlbertoFacultad de Bioquímica, Química y Farmacia, Universidad Nacional de Tucumán (UNT), Ayacucho 471, San Miguel de Tucumán CP 4000, Argentina.ORCID 0000-0002-4173-9499
Mario Eduardo ArenaFacultad de Bioquímica, Química y Farmacia, Universidad Nacional de Tucumán (UNT), Ayacucho 471, San Miguel de Tucumán CP 4000, Argentina.ORCID 0000-0003-1984-5233

Funding

Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación PICT 2018-02071 and 02514, PICT 2021-0060, PICT-2021-I-A-00439 IConsejo Nacional de Investigaciones Científicas y Técnicas PUE 0021National University of Tucumán PIUNT D702, D708, and D715
6 · The paper itself

Abstract

The escalating prevalence of antibiotic-resistant bacteria poses a grave threat to human health, necessitating the exploration of novel alternatives to conventional antibiotics. This study investigated the impact of extracts derived from the supernatant of four lactic acid bacteria strains on factors contributing to the pathogenicity of three

Indexed as

biofilmchloroform extractlactic acid bacteriaquorum sensingStaphylococcus aureus

Identifiers

PMID38666973
PMCPMC11047364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.